心脏磁共振对ST段抬高型心肌梗死患者左心室逆重构的早期预测
回顾性纳入86例ST段抬高型心肌梗死(STEMI)患者,分为左心室逆重构(r-LVR)组37例与无r-LVR组49例,比较两次心脏磁共振(CMR)的左心室容积、梗死特征及整体与区域心肌功能,采用CMR特征追踪评估应变与位移,逻辑回归分析r-LVR预测因素。结果显示初始CMR时两组整体心功能无差异,但r-LVR组梗死区径向与纵向位移更高;随访CMR时r-LVR组左心室射血分数更高、左心室容积更低、总强化质量更低,梗死区径向与环向应变及径向位移更高。微血管阻塞质量(OR 0.779,95%CI 0.613-0.989,P=0.041)与梗死区峰值纵向位移(OR 1.448,95%CI 1.044-2.008,P=0.026)是r-LVR的独立预测因素。
要点
- 初始CMR时r-LVR组梗死区径向与纵向位移更高,但两组整体心功能无差异。
- 随访CMR时r-LVR组左心室射血分数更高、左心室容积更低、总强化质量更低。
- 微血管阻塞质量与梗死区峰值纵向位移是r-LVR的独立预测因素。
核心结论
- 初始CMR时两组整体心功能无差异,但r-LVR组梗死区位移更高且心肌损伤更少;r-LVR组心功能恢复更好;微血管阻塞质量与梗死区峰值纵向位移是r-LVR的独立预测因素。
研究设计与样本
- 回顾性研究,纳入86例STEMI患者(中位年龄56岁),分为r-LVR组37例与无r-LVR组49例,采用CMR分析左心室容积、梗死特征及整体与区域心肌功能,通过CMR特征追踪评估应变与位移,采用逻辑回归分析r-LVR预测因素。
关键影像表现/征象
- 初始CMR时r-LVR组梗死区径向与纵向位移均高于无r-LVR组(分别P<0.05)。
- 第二次CMR时r-LVR组左心室射血分数高于无r-LVR组,左心室容积与总强化质量低于无r-LVR组(均P<0.05)。
- 第二次CMR时r-LVR组梗死区径向与环向应变及径向位移均高于无r-LVR组(均P<0.05)。
- r-LVR组心肌损伤与功能恢复优于无r-LVR组。
诊断标准与关键数值
- 微血管阻塞质量预测r-LVR的OR为0.779(95%CI 0.613-0.989),P=0.041。
- 梗死区峰值纵向位移预测r-LVR的OR为1.448(95%CI 1.044-2.008),P=0.026。
临床应用与阅片要点
- 初始CMR整体心功能无差异时,梗死区位移参数可能有助于早期识别r-LVR潜能。
- 微血管阻塞质量与梗死区峰值纵向位移可作为r-LVR的预测指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the changes in cardiac magnetic resonance (CMR) characteristics and investigate the predictors of reverse left ventricular remodeling (r-LVR) in ST-segment elevation myocardial infarction (STEMI) patients.
MATERIALS AND METHODS: Eighty-six STEMI patients (median 56 years) were retrospectively studied. The patients were divided into r-LVR and without r-LVR groups. CMR analysis included LV volume, infarct characteristics, and global and regional myocardial function. The strain and displacement were assessed by CMR-feature tracking. The predictors of r-LVR were analyzed by the logistic regression method.
RESULTS: There were 37 patients in the r-LVR group and 49 patients in the without r-LVR group. At initial CMR, there was no difference in LV volume and global cardiac function between the two groups. However, the infarct zone radial and longitudinal displacements were higher in the r-LVR group (p < 0.05, respectively). At the second CMR, the r-LVR group showed higher LVEF, lower LV volume, and total enhanced mass (all p < 0.05). The infarct zone radial and circumferential strains and radial displacement were higher in the r-LVR group (all p < 0.05). The r-LVR group had better recovery of myocardial injury and function. Of note, microvascular obstruction (MVO) mass (odds ratio: 0.779 (0.613-0.989), p = 0.041) and infarct zone peak longitudinal displacement (PLD) (odds ratio: 1.448 (1.044-2.008), p = 0.026) were independent predictors of r-LVR.
CONCLUSIONS: At initial CMR, there were no differences in global cardiac function between the two groups, but infarct zone displacements were higher in the r-LVR group. The r-LVR group had better recovery of cardiac function. In addition, MVO mass and infarct zone PLD were independent predictors of r-LVR.
CLINICAL RELEVANCE STATEMENT: Our study assessed changes in cardiac structure, function, and tissue characteristics after STEMI by CMR, investigated the best predictors of r-LVR in STEMI patients, and laid the foundation for the development of new parameter-guided treatment strategies for STEMI patients.
KEY POINTS: • At initial CMR, the reverse left ventricular remodeling (r-LVR) group had less myocardial damage and higher infarct zone displacement, but there were no differences in global function between the two groups. • Both groups showed recovery of myocardial injury and cardiac function over time, but the r-LVR group had less enhanced mass and better cardiac function compared to the without r-LVR group at the second CMR. • Microvascular obstruction mass and infarct zone peak longitudinal displacement by cardiac magnetic resonance feature-tracking were significant predictors of r-LVR in STEMI patients.
引用
- Cui J, Zhao Y, Qian G, et al. Cardiac magnetic resonance for the early prediction of reverse left ventricular remodeling in patients with ST-segment elevation myocardial infarction. Eur Radiol. 2023. PMID: 37458756. doi:10.1007/s00330-023-09907-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。